Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

NCT07227298 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced/Metastatic Non-Small Cell Lung Cancer
Carcinoma, Non-Small Cell Lung
Non-Small Cell Lung Cancer

Interventions

BIOLOGICAL: PF-08634404
BIOLOGICAL: Sigvotatug Vedotin
BIOLOGICAL: Combination Agent 1

Sponsor

Pfizer